论文部分内容阅读
新研究发现,常用于治疗高血压的阻滞剂,在减慢某些严重癌症的发展中可发挥重大作用。俄亥俄州大学行为医学研究(IBMR)和综合癌症中心研究所的研究人员在对丹麦癌症登记处成千上万医疗记录的回顾研究发现:使用特定阻滞剂的皮肤黑色素瘤患者的死亡率远远低于未服用该药物的患者。该研究发表在《癌症流行病学、生物标记及预防》(Cancer Epidemiology,Biomarkers&Prevention)上。若该结论得到临床试验验证,这将为预后不良的癌症患者提供一个新的辅助治疗。
The new study found that commonly used in the treatment of hypertension blockers, in the slow down of certain serious cancer development can play a significant role. A retrospective study of tens of thousands of medical records of the Danish Cancer Register with researchers at the Ohio University Institute for Behavioral Medicine (IBMR) and Center for Integrated Cancer Research found that the mortality of skin melanoma patients with specific blockers was far Lower than those who did not take the drug. The study is published in Cancer Epidemiology, Biomarkers & Prevention. If this conclusion is confirmed by clinical trials, this will provide a new adjuvant therapy for cancer patients with poor prognosis.